Information  X 
Enter a valid email address

Cineworld Group plc (CINE)

  Print      Mail a friend       Annual reports

Friday 17 January, 2020

Cineworld Group plc

Director/PDMR Shareholding

RNS Number : 2111A
Cineworld Group plc
17 January 2020
 

17 January 2020

CINEWORLD GROUP PLC (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

In accordance with Article 19(3) of the Market Abuse Regulation (2014/596/EU), the following transactions were made by persons discharging managerial responsibilities:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Eric Senat

2

 

Reason for the notification

a)

 

Position/status

 

Non-Executive Director and Senior Independent Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Cineworld Group plc

b)

 

LEI

213800J2J3TOOI176M73

4

 

Details of the transaction

a)

Description of the financial instrument, type of instrument

Identification code

 Ordinary shares of £0.01 each in Cineworld Group plc

 

  GB00B15FWH70

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price and volume

 

Transaction

Price

Volume

Total

1)

£2.71

1,533

£4,154.43

2)

£3.03899

1,650

£5,014.33

3)

£2.172

1,894

£4,113.77

4)

£1.9902

2,005

£3,990.35



d)

 

Aggregated information

Volume 7,082

Total £17,272.88

e)

Date of the transaction(s)

1)   10 July 2018

2)   09 October 2018

3)   08 October 2019

4)   14 January 2020

f)

Place of the transaction

 London Stock Exchange, main market (XLON)

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZDLFFBFLBBBF

a d v e r t i s e m e n t